These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37396024)

  • 21. The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis.
    Zhang H; Ren D; Jin X; Wu H
    Cancer Cell Int; 2020; 20():462. PubMed ID: 32982584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis.
    Kim MR; Kim AS; Choi HI; Jung JH; Park JY; Ko HJ
    PLoS One; 2020; 15(7):e0236445. PubMed ID: 32716955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score.
    Hirahara N; Matsubara T; Kaji S; Kawabata Y; Hyakudomi R; Yamamoto T; Uchida Y; Ishitobi K; Takai K; Tajima Y
    Oncotarget; 2020 Nov; 11(45):4169-4177. PubMed ID: 33227100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis.
    Jiang Y; Xu D; Song H; Qiu B; Tian D; Li Z; Ji Y; Wang J
    BMJ Open; 2021 Sep; 11(9):e048324. PubMed ID: 34593492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis.
    Fang E; Wang X; Feng J; Zhao X
    Dis Markers; 2020; 2020():8736509. PubMed ID: 31998420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis.
    Zhou Y; Liu Z; Cheng Y; Li J; Fu W
    J Gastrointest Surg; 2024 Apr; 28(4):559-565. PubMed ID: 38583910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients.
    Wu D; Wang X; Shi G; Sun H; Ge G
    Aging (Albany NY); 2021 Jan; 13(1):1410-1421. PubMed ID: 33406501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis.
    Song X; Zhang H; Yin F; Guo P; Yang X; Liu J; Han Y; Ren Z
    Mediators Inflamm; 2021; 2021():3456629. PubMed ID: 34720749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
    Jin J; Hu K; Zhou Y; Li W
    PLoS One; 2017; 12(9):e0184412. PubMed ID: 28886134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential impact of platelet-to-lymphocyte ratio on prognosis in patients with colorectal cancer: A systematic review and meta-analysis.
    Guo G; Hu X; Gao T; Zhou H; Li B; Zhou C; Yu B; Wang G
    Front Surg; 2023; 10():1139503. PubMed ID: 37051571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting outcomes of Lung Cancer using the modified glasgow prognostic score: A systematic review and meta-analysis.
    Min Y; Li X; Chen H; Xu Y; Lan G
    Pak J Med Sci; 2024; 40(3Part-II):534-543. PubMed ID: 38356845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer.
    Guthrie GJ; Roxburgh CS; Farhan-Alanie OM; Horgan PG; McMillan DC
    Br J Cancer; 2013 Jul; 109(1):24-8. PubMed ID: 23799846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
    Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
    Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Modified Glasgow Prognostic Score and Survival in Colorectal Cancer: A Pooled Analysis of the Literature.
    Petrelli F; Barni S; Coinu A; Bertocchi P; Borgonovo K; Cabiddu M; Ghilardi M; Zaniboni A
    Rev Recent Clin Trials; 2015; 10(2):135-41. PubMed ID: 25778832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
    Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
    J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis.
    Li LQ; Bai ZH; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Wen J; Li JZ
    Front Oncol; 2020; 10():30. PubMed ID: 32082998
    [No Abstract]   [Full Text] [Related]  

  • 39. Modified Glasgow prognostic score as a prognostic factor for renal cell carcinomas: a systematic review and meta-analysis.
    Hu X; Wang Y; Yang WX; Dou WC; Shao YX; Li X
    Cancer Manag Res; 2019; 11():6163-6173. PubMed ID: 31308752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
    Li Y; Liu X; Zhang J; Yao W
    Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.